Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Treatment strategy of post endoscopic submucosal dissection (ESD) ulcer is not yet
conclusive. Rebamipide is a mucosal protective agent widely used in East Asia and has good
effect on quality of ulcer healing (QOUH). The investigators will conduct this randomized
controlled study to assess the effect of a combination therapy of rebamipide and proton pump
inhibitor (PPI) on post ESD ulcer healing.